Nick Marko and Geisinger’s Health Data Journey
Geisinger Health System’s Chief Data Officer, Nicholas Marko (he is also a practicing physician, the director of neurosurgical oncology at Geisinger), joined me recently to speak about the points of…
Medical Advancement: 6 Things to Know About Your Body
The body is such an intricate creation. There are facts about the body that science and medicine are still discovering. Be that as it may, in order to maintain optimal…
How to Keep Your Medical Staff Focused During Work
Nowhere is it more important for employees to be on-point than in the medical industry. A marketing professional who falls asleep won't usually kill anyone. He might kill the bottom…
Google’s Plan to Take the Healthcare Industry By Storm
Get ready for a shakeup: Google is setting its sights on the healthcare industry. Google built its empire by establishing itself as a monolith of search. Now, it intends to…
Major EU Remote Monitoring Pilot Results
This post looks at some lessons learned from remote monitoring projects in Europe. This and subsequent posts are based on my last eight years of supporting these projects combined with some thoughts from…
Tips for Helping Patients Navigate Chronic Conditions
Few things are as difficult for a healthcare professional as dealing with patients who have chronic conditions and ongoing discomfort. Not only do you have to help them feel better,…
5 Major Challenges in Healthcare Recruitment Today
A Conversation with Jason Campbell, Talent Acquisition Manager, by Chad Harrington A Conversation with Jason Campbell, Talent Acquisition Manager, by Chad HarringtonFor this post I interviewed Jason Campbell, Talent Acquisition…
The Medical Device Sales Tax Suspension Could Be a Huge Opportunity – Don’t Let it Go to Waste
Ding dong, the wicked 2.3% medical sales excise tax is dead. If your company finds itself with extra funds, how will you reinvest? Ding dong, the wicked 2.3% medical sales…
Help us, IBM-Dell-Apple, you’re our only hope.
I've been on the road a lot over the last six months, getting the chance to interact with (and, I hope, influence), audiences in health tech and health policy. There's so…
